RS

Raghav Shamrao Kulkarni

Active Director Director DIN 00029688
DIN 00029688 First appointment Sep 1995 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 4 historical roles
Total affiliations 6 Since Sep 1995
Shareholding value •••• Premium profile

About Raghav Shamrao Kulkarni

Data last updated:

Raghav Shamrao Kulkarni is a Director at Artistree Medical Private Limited (since 2023) and Director at Ark Lasers India Private Limited (since 2018). The companies operate in Healthcare, Engineering and Life Sciences. The 2 current companies with reported revenue have a combined latest revenue of ₹92.4 Lakh; the largest is Artistree Medical Private Limited at ₹92.2 Lakh (FY 2019). Earlier, Raghav Shamrao Kulkarni was a Director at Beluga Biozymes Private Limited (2002–2014) and Whole-Time Director at Medicure Private Limited (1999–2020) and 2 more.

DIN 00029688
Primary Designation Director
Industry Healthcare
First Appointment 18 Sep 1995
Oldest Company Age 14 yrs
Largest company Artistree Medical Private Limited · ₹92.2 Lakh (FY 2019)
Combined revenue ₹92.4 Lakh across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Artistree Medical Private Limited U74900MH2012PTC233521
Director30 Sep 20232012₹92.2 Lakh (FY 2019)Active
Ark Lasers India Private Limited U33111MH2014PTC260192
Director22 Aug 20182014₹12,000 (FY 2019)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Beluga Biozymes Private Limited U24230MH2002PTC134971
Director21 Feb 20022002₹50,000 (FY 2019)Active
Medicure Private Limited U24231MH1998PTC117391
Whole-Time Director11 Nov 19991998₹1.2 Lakh (FY 2019)Active
Alfa Lasers India Private Limited U51109MH2011PTC212174
Director11 Jan 20112011₹8 Lakh (FY 2019)Active
Director18 Sep 19951995Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Raghav Shamrao Kulkarni

Directorship timeline

Open interactive timeline →
Ark Lasers India Private Limited
Artistree Medical Private Limited
Beluga Biozymes Private Limited
Medicure Private Limited
Premium access

Shareholding and investment profile for Raghav Shamrao Kulkarni

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Raghav Shamrao Kulkarni

Raghav Shamrao Kulkarni currently holds 2 directorships: Artistree Medical Private Limited (Director, since 30 Sep 2023, revenue ₹92.2 Lakh (FY 2019)); Ark Lasers India Private Limited (Director, since 22 Aug 2018, revenue ₹12,000 (FY 2019)).

Raghav Shamrao Kulkarni was first appointed on 18 Sep 1995 as Director at Cynic Finance And Leasing Private Limited. The most recent appointment on record is 30 Sep 2023 at Artistree Medical Private Limited.

The 2 current companies of Raghav Shamrao Kulkarni that report revenue have a combined latest revenue of ₹92.4 Lakh: Artistree Medical Private Limited ₹92.2 Lakh (FY 2019); Ark Lasers India Private Limited ₹12,000 (FY 2019).

Raghav Shamrao Kulkarni held 4 earlier board appointments: Beluga Biozymes Private Limited (Director, 21 Feb 2002 to 22 Feb 2014); Medicure Private Limited (Whole-Time Director, 11 Nov 1999 to 15 Jun 2020); Alfa Lasers India Private Limited (Director, 11 Jan 2011 to 12 Jan 2016); Cynic Finance And Leasing Private Limited (Director, 18 Sep 1995 to 27 Dec 2009).

The current boards of Raghav Shamrao Kulkarni's companies include Aarti Raghav Kulkarni (Artistree Medical Private Limited), Arundhati Sanjay Bandivdekar (Ark Lasers India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available